Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies

This interactive panel discussion aimed at early stage biotechs features Kathy Fernando, Senior Vice President and Global Head and Shaan Gandhi, Head of Strategic Partnerships at Pfizer Ignite, a new end-to-end developmental and clinical services offering for biotech innovators designed to help advance their novel therapies to market. Joining the conversation are Deb Geraghty, CEO of Anokion, a private biotech with a proprietary immune tolerance platform focused on treating autoimmune disease and Timothy Pearson, CEO of Carrick Therapeutics, a private clinical-stage biopharmaceutical company focused on building the future of oncological therapy, to share their insights and experience building foundational relationships in support of their programs and mission. Rounding out the panel to provide a VC perspective is Deborah Palestrant, Partner: Executive Chair of the 4:59 Initiative with 5 am Ventures.